AI assistant
BIO-TECHNE Corp — Director's Dealing 2026
Feb 19, 2026
30718_dirs_2026-02-19_8773f5f1-ae04-4139-812b-20433fd5bc78.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2026-02-17
Reporting Person: Herr Amy E. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2026-02-17 | Common Stock | S | 1976 | $59.105 | Disposed | 200 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2680 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $72.05 | 2035-02-03 | Common Stock (2415) | 2415 | Direct |
| Stock Option (Right to Buy) | $60.96 | 2035-10-30 | Common Stock (3777) | 3777 | Direct |
| Stock Option (Right to Buy) | $47.60 | 2026-08-07 | Common Stock (6636) | 6636 | Indirect |
| Stock Option (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (4472) | 4472 | Indirect |
| Stock Option (Right to Buy) | $120.46 | 2028-08-06 | Common Stock (2076) | 2076 | Indirect |
| Stock Option (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (2104) | 2104 | Indirect |
| Stock Option (Right to Buy) | $84.61 | 2030-08-15 | Common Stock (1084) | 1084 | Indirect |
| Stock Option (Right to Buy) | $74.91 | 2034-08-15 | Common Stock (1468) | 1468 | Indirect |
| Stock Option (Right to Buy) | $72.05 | 2035-02-03 | Common Stock (344) | 344 | Indirect |
| Restricted Stock Units | $ | Common Stock (118) | 118 | Indirect | |
| Restricted Stock Units | $ | Common Stock (320) | 320 | Indirect | |
| Restricted Stock Units | $ | Common Stock (77) | 77 | Indirect | |
| Restricted Stock Units | $ | Common Stock (932) | 932 | Indirect | |
| Stock Option (Right to Buy) | $53.60 | 2035-08-15 | Common Stock (2735) | 2735 | Indirect |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.091 to $59.1390, inclusive. The reporting person undertakes to provide Bio-Techne Corporation, any security holder of Bio-Techne Corporation, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F2: This option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.
F3: Fully vested.
F4: Options to purchase 528 shares vest on 8/15/2023 and 8/15/2025; and options to purchase 524 shares vest on 8/15/2024 and 8/15/2026.
F5: Options to purchase 271 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2026 and 8/15/2027.
F6: Options to purchase 367 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.
F7: Options to purchase 86 shares vest on each of 2/3/2026, 2/3/2027, 2/3/2028 and 2/3/2029.
F8: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F9: 118 restricted stock units vest on 8/15/2026.
F10: 160 restricted stock units vest on each of 8/15/2026 and 8/15/2027.
F11: 38 restricted stock units vest on 2/3/2027 and 39 restricted stock units vest on 2/3/2028.
F12: 311 restricted stock units vest on each of 8/15/2026 and 8/15/2027, and 310 restricted stock units vest on 8/15/2028.
F13: Options to purchase 912 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 911 shares vest on 8/15/2028.